Exploring the Role of Apigenin in Neuroinflammation: Insights and Implications

Int J Mol Sci. 2024 May 6;25(9):5041. doi: 10.3390/ijms25095041.

Abstract

Neuroinflammation, a hallmark of various central nervous system disorders, is often associated with oxidative stress and neuronal or oligodendrocyte cell death. It is therefore very interesting to target neuroinflammation pharmacologically. One therapeutic option is the use of nutraceuticals, particularly apigenin. Apigenin is present in plants: vegetables (parsley, celery, onions), fruits (oranges), herbs (chamomile, thyme, oregano, basil), and some beverages (tea, beer, and wine). This review explores the potential of apigenin as an anti-inflammatory agent across diverse neurological conditions (multiple sclerosis, Parkinson's disease, Alzheimer's disease), cancer, cardiovascular diseases, cognitive and memory disorders, and toxicity related to trace metals and other chemicals. Drawing upon major studies, we summarize apigenin's multifaceted effects and underlying mechanisms in neuroinflammation. Our review underscores apigenin's therapeutic promise and calls for further investigation into its clinical applications.

Keywords: 4′,5,7-trihydroxyflavone; apigenin; brain; cancer; flavonoids; natural products; neurodegenerative diseases; neuroinflammation; nutraceutical; phytochemical.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / pharmacology
  • Anti-Inflammatory Agents* / therapeutic use
  • Apigenin* / pharmacology
  • Apigenin* / therapeutic use
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Neuroinflammatory Diseases* / drug therapy
  • Neuroinflammatory Diseases* / metabolism
  • Oxidative Stress / drug effects

Substances

  • Apigenin
  • Anti-Inflammatory Agents

Grants and funding

This research was funded by the University of Bourgogne.